AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05705843 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Vancomycin
Description: IV Vancomycin will be started in the pre-operative period approximately 1 hour prior to incision (vancomycin dose weight-based at approximately 15mg/kg generally 1000-1750mg in 500mL NS).
Study NCT05901623 — intervention group
Intervention type: OTHER
Intervention: 'Ages and Stages Questionnaries' (ASQ)
Description: ''ASQ' is a screening tool for assessing the development of infants and preschoolers in the areas of communication, fine motor, gross motor, problem-solving and personal-social development, and 'ASQ:SE' is a screening tool for social-emotional development
Study NCT05052840 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle endurance training (MET)
Description: Experimental group will be given MET Program, stretching \& strengthening exercises and Hot packs (for 15 minutes). MET program will include warm up, endurance and cool down exercises. The warm up and cool down period will be consisted of 5-minute walking, and 10 repetitions of stretching exercises. Endurance exercises will consist of 4 levels.
Study NCT05052840 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Treatment
Description: Conventional treatment group will be given hot packs (for 15 minutes) and Strengthening \& stretching exercise program including:~STRETCHING EXERCISES (lumbar extensor muscles, iliopsoas muscles, hamstring muscles, gastrocnemius muscles and pectoral muscles).~STRENGTHENING EXERCISES (rectus abdominus crunch, oblique crunch, pelvic elevation, single leg pelvic elevation, lumbal spine extension, on hands and knees position with the raise of one leg, on hands and knees position with the raise of opposite arm and leg). Each exercise will be repeated 10 times.
Study NCT05052840 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Treatment
Description: Conventional treatment group will be given hot packs (for 15 minutes) and Strengthening \& stretching exercise program including:~STRETCHING EXERCISES (lumbar extensor muscles, iliopsoas muscles, hamstring muscles, gastrocnemius muscles and pectoral muscles).~STRENGTHENING EXERCISES (rectus abdominus crunch, oblique crunch, pelvic elevation, single leg pelvic elevation, lumbal spine extension, on hands and knees position with the raise of one leg, on hands and knees position with the raise of opposite arm and leg). Each exercise will be repeated 10 times.
Study NCT06378177 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LVGN6051 Monoclonal Antibody Injection
Description: LVGN6051 Monoclonal Antibody Injection:1 mg/kg or 2 mg/kg, every 3 weeks(Q3W) , on the first day of the treatment cycle for up to 2 years.
Study NCT06378177 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: toripalimab Injection
Description: toripalimab Injection: 240mg fixed dose,Q3W, on the first day of the treatment cycle for up to 2 years.
Study NCT06251362 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sleep restriction
Description: Participants will experience a night of acute sleep restriction. During this night, they will sleep 3 hours less than usual.
Study NCT06378177 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel injection
Description: paclitaxel Injection:5ml:100 mg/m2(80 mg/m2 or 60 mg/m2 can be used if necessary),Q3W,on the first and eighth day of the treatment cycle for up to 2 years
Study NCT05833204 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic colporrhaphy with 0-caliber barbed absorbable suture
Description: After the total laparoscopic hysterectomy, the colporrhaphy will be performed using a 0-caliber barbed absorbable suture (V-Loc ™, Covidien, Medtronic)
Study NCT05833204 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic colporrhaphy with standard 0-caliber absorbable suture
Description: After the total laparoscopic hysterectomy, the colporrhaphy will be performed using a 0-caliber absorbable suture made of a coated braided thread (Vicryl; Ethicon Inc, Sommerville, NJ)
Study NCT06270706 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PLN-101095
Description: PLN-101095
Study NCT06270706 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab
Study NCT05374278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [18F]RP-115 PET/MRI or PET/CT and MRI
Description: An I.V. bolus injection of up to 10 millicurie (mCi) \[18F\]RP-115 will be administered, followed by a PET/MRI scan or by a combination of PET/CT and MRI
Study NCT04738292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Onapristone
Description: Onapristone is a type I antiprogestin which prevents the PgR from dimerizing and blocks ligand induced protein kinase-mediated phosphorylation of the PgR.
Study NCT04738292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Description: Fulvestrant binds, blocks and degrades the ER, completely inhibiting ER signaling.
Study NCT06209918 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: bioptron light therapy
Description: patient will be sitting on comfortable chair with the hand placed on an armrest in an extended and supinated position. Firstly, the skin over the wrist area will be exposed and cleaned by alcohol to achieve maximal penetration of light. Then, the bioptron device will be held perpendicular to the surface of the treated area, at a distance of 10 cm.
Study NCT06209918 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: wrist brace
Description: will keep the wrist in a neutral position, not bent back or bent down too far
Study NCT06094036 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Structured and personalized program of physical exercise
Description: In line with the most recent guidelines, exercise prescription will require the clear definition of modality, intensity, frequency, duration and progression of exercise, tailored on patient's clinical conditions and goals.~This intervention will be accompanied by a nutrition program aiming for proper dietary habits in terms of both quantity and quality.
Study NCT05292092 — intervention group
Intervention type: DRUG
Intervention: Essential pro
Description: Patients in whom treatment with (Essential Pro) has been attempted
Study NCT05382143 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atosiban
Description: Pilot study
Study NCT06400810 — intervention group
Intervention type: DEVICE
Intervention: Analog Devices Inc.
Description: Wearable wrist device that collects Photoplethysmography, accelerometer data among other parameters.
Study NCT06237270 — intervention group
Intervention type: PROCEDURE
Intervention: Nerve transfer surgery for elbow flexion
Description: A functioning but less important nerve (e.g. spinal accessory nerve, phrenic nerve, fascicle of median nerve, or fascicle of ulnar nerve) was transferred to nerves innervating biceps or brachialis muscle to restore elbow flexion.
Study NCT06285500 — intervention group
Intervention type: OTHER
Intervention: Patient-specific treatments
Description: Treatment will be decided specifically for the patient based on biomarker test results.
Study NCT05184855 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Blueberry
Description: Blueberry powder intake
Study NCT05184855 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo powder intake
Study NCT05267704 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Samsung Gear Virtual Reality Headset
Description: VR headset displaying preselected game during renal biopsy
Study NCT06079294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FDG PET
Description: Brain FDG PET performed 3 months after treatment initiation
Study NCT06517381 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Online Warning Signs of Mental Illness Literacy Program
Description: Digital Online Warning Signs of Mental Illness Literacy Program is comprised of 30-minute pre-recorded video and question-and-answer sessions. The videos were followed by case studies, success stories, and interactive question-and-answer sessions
Study NCT05453721 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Indocyanine green fluorescence imaging method
Description: Using indocyanine green fluorescence imaging method to identify intersegmental plane in segmentectomy
Study NCT05453721 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Modified inflation-deflation method
Description: Using modified inflation-deflation method to identify intersegmental plane in segmentectomy
Study NCT05550324 — intervention group
Intervention type: PROCEDURE
Intervention: Blood draw
Description: One time intravenous blood draw
Study NCT05385406 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: HPV genotyping
Description: Genotyping will be obtained by the Xpert system which uses 5 color channels containing primers and probes for the detection of specific genotypes or pooled results as follows: i) HPV 16, ii) HPV 18/45 in pooled result, iii) HPV types 31, 33, 35 52, or 58, in pooled result, iv) HPV types 51 or 59, in pooled result, and v) HPV types 39, 56, 66 or 68 in pooled result.
Study NCT05385406 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Visual inspection after application of acetic acid
Description: After application of acetic acid and Lugol's iodine, the cervix will be assessed using simplified ABCD criteria (A= acetowhite lesion within the transformation zone, B = spontaneous bleeding or upon slight touch, C (optional) = Lugol-positive coloring of acetowhite lesions, D = diameter > 5mm of acetowhite lesion).
Study NCT05500937 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: UDCA
Description: UDCA vs. placebo together with statin in ASCVD patients
Study NCT05500937 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: UDCA
Description: UDCA vs. placebo together with statin in ASCVD patients
Study NCT06307379 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: only observational
Study NCT05426174 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA NA vaccine
Description: Pharmaceutical form: Suspension for injection Route of administration: Intramuscular
Study NCT05426174 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: High Dose Quadrivalent Influenza Vaccine
Description: Pharmaceutical form: Suspension for injection Route of administration: Intramuscular
Study NCT06305481 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: P200TE
Description: SLO and OCT imaging
Study NCT04941989 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HTL0022562
Description: HTL0022562
Study NCT04941989 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study NCT04556266 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR T-Cell Infusion
Description: Dose Level -1: 1 x 10\^4 cells/kg Dose Level 1: 1 x 10\^5 cells/kg Dose Level 2: 2 x 10\^5 cells/kg Dose Level 3: 4 x 10\^5 cells/kg
Study NCT06095687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness Meditation
Description: Five, 20-minute audio-recorded training sessions of mindfulness of breath and body meditation, practiced over consecutive days, delivered remotely via Qualtrics.
Study NCT06095687 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Clinical Hypnosis
Description: Five, 20-minute audio-recorded training sessions of clinical hypnosis with suggestions targeting pain management, practiced over consecutive days, delivered remotely via Qualtrics.
Study NCT04660383 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Inspiratory Muscle Training
Description: Patients will be submitted to three weekly IMT sessions in three different intensities for a period of twelve weeks, totaling 36 sessions.
Study NCT04660383 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training
Description: Patients will be submitted to three weekly IMT sessions in three different intensities for a period of twelve weeks, totaling 36 sessions.
Study NCT06140134 — intervention group
Intervention type: PROCEDURE
Intervention: Liver Transplant
Description: Whole liver allotransplantation will be performed for patients on the liver transplant waiting list
Study NCT05170113 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Alpinia galanga formulation
Description: Alpinia galanga formulation capsule- 1 capsule daily
Study NCT05170113 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Theacrine formulation
Description: Theacrine formulation capsule- 1 capsule daily
Study NCT05170113 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine formulation
Description: Caffeine formulation capsule- I capsule daily
Study NCT05170113 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule- 1 capsule daily
Study NCT05018793 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: autologous adipose derived mesenchymal stem cells
Description: cultured autologous adult adipose derived mesenchymal stem cells
Study NCT05255822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INNA-051
Description: Liquid for intra-nasal administration
Study NCT05255822 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Liquid for intra-nasal administration
Study NCT05072288 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote activity program
Description: Participant will have to do exercise at home everyday (15min/day)
Study NCT05716464 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle medicine intervention
Description: The lifestyle medicine intervention includes six weekly sessions (i.e., participants will receive the intervention once per week) that are related to the following topics: (a) lifestyle psychoeducation, (b) physical activity, (c) dietary recommendation, (d) stress management, (e) sleep management and (f) motivation and goal-setting techniques. Each topic will be delivered during each face-to-face session and the duration of each session will be around 120 minutes.
Study NCT05716464 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for depression (CBT-D)
Description: The group-based CBT-D therapy includes six weekly sessions (i.e., participants will attend one 120-minute, face-to-face group therapy per week, and will be asked to practice taught-skills every day, for 42 days) that are related to the following topics: (a) psychoeducation, (b) cognitive restructuring, (c) behavioral activation, (d) self-care and relapse prevention.
Study NCT05785169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TRAncenDS
Description: The HP+ curriculum includes total-site training and co-facilitation via participatory modules. To transform clinic culture, a multi-level approach that includes the whole facility and reaches all parties is required. The intervention aims to modify top-down mechanisms of influence. TRAnscenDS is modeled on these principles and supports the development of multiple SRD-reduction strategies (instituting comprehensive anti-racist and Diversity, Equity and Inclusion policies, monitoring and feedback systems; workforce equity), at the top two levels of the socioecological model (organizational/policy and systems/providers/staff), to in turn impact individual-level out-comes.
Study NCT06474819 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pacemaker implant
Description: All patients in the study will have a clear indication for a permanent pacemaker. The type of device (single or dual chamber) will be chosen as per clinical practice. The only difference between the two groups of the study will be the position of the ventricular lead.
Study NCT06474819 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pacemaker implant
Description: All patients in the study will have a clear indication for a permanent pacemaker. The type of device (single or dual chamber) will be chosen as per clinical practice. The only difference between the two groups of the study will be the position of the ventricular lead.
Study NCT05129228 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OCT-guided saphenous vein CABG
Description: OCT examination of harvested saphenous vein conduits will indicate pathology. Under the surgeon's discretion the conduit segments with pathology will not be grafted.
Study NCT01354184 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CRD007
Study NCT05051163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ceftriaxone Sodium
Description: 7 days of once daily dosing
Study NCT05051163 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ampicillin
Description: 7 days of 6 hourly dosing
Study NCT05051163 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gentamicin
Description: 7 days of once daily dosing
Study NCT01354184 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: CRD007 matching placebo
Study NCT05286320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib/Pembrolizumab plus SBRT combinations
Description: Five-fraction SBRT (week 4-week 5) to PVTT and connected HCC tumor in 2 weeks Lenvatinib 12/8 mg/day for 96 weeks (no lenvatinib from 7 day before SBRT to 7 days after SBRT) Pembrolizumab 200 mg q 3 week x 32 cycles
Study NCT06317974 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breastfeeding education based on the Health Belief model
Description: Training was given face to face with the participant, lasting approximately 40 minutes. One week after the training presentation, three short messages about the training were sent to the couples (both the pregnant woman and her partner) every other day. Two weeks after the training was given, a phone call was made for feedback. Post-test data were taken four weeks later.
Study NCT05058963 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mantram repetition program
Description: Week 1: Define and describe the characteristics of a mantram as taught by Eknath Easwaran and how it relates to posttraumatic stress (PTSD) Week 2: Identify ways to choose and use mantram repetition for training attention and targeting craving.~Introduction to substance craving and identify triggers for use. Week 3: Describe the relationship between the PTSD/stress response, mantram repetition and the relaxation response Week 4: Describe at least two benefits of slowing down versus automatic pilot for stress reduction Week 5: Describe at least two benefits of one-pointed attention versus multitasking for stress reduction Week 6: Demonstrate how one-pointed attention and slowing down complement each other for making healthy choices Week 7: List at least five strategies for making mantram repetition a part of your life Week 8: Discuss applications of mantram repetition, one-pointed attention and slowing down for overall health and substance use
Study NCT05240079 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heart rate measurement with Caducy system (twice). SpO2 measurement with Caducy system (Twice).
Description: Heart rate and SpO2 measurement with Caducy (the visage of the subject is filmed 30 seconds and 1 minute with a camera) and heart rate and SpO2 measurement with gold standard (heart rate monitor and oximeter pod linked to an acquisition station). The procedure is repeated twice.
Study NCT05429905 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Phase I
Description: * Dose level 0: CAR+CD3+ 0.4 x 10e6/kg (de-escalation dose)~* Dose level 1: CAR+CD3+ 1 x 10e6/kg (starting dose)~* Dose level 2: CAR+CD3+ 2.5 x 10e6/kg.~Dose-escalations for adults and paediatrics will be performed in 2 independent strata for determination of RP2D.
Study NCT05429905 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Phase II
Description: RP2D will be determined in Phase I
Study NCT05310851 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PIOMI and non-nutritive sucking
Description: PIOMI group; The first three minutes of the five minutes include massages aimed at strengthening the cheeks, lips, gums and tongue; the last two minutes consist of non-feeding suction application.~Infants in the Non-nutritive sucking group will receive pacifier 3 minutes before 1 hour any feeding time and, 2 minutes before 10 minutes.
Study NCT06315504 — intervention group
Intervention type: OTHER
Intervention: Observation
Description: Observation
Study NCT06273592 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Animal-based meal
Description: Consuming a single plant-based meat or a single animal meat meal and measuring the meals impact on erectile function with the Rigiscan™ device.
Study NCT06273592 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Plant-based meat meal
Description: Consuming a single plant-based meat or a single animal meat meal and measuring the meals impact on erectile function with the Rigiscan™ device.
Study NCT05512663 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Irreversible Electroporation (IRE)
Description: The area of the prostate that was positive for cancer based on the transperineal prostate biopsy will be targeted for ablation via the NanoKnife System. An MRI/TRUS fusion device probe will be placed in the rectum and the prostate will be visualized in both sagittal and axial views. The ultrasound grid which was used during the mapping biopsy will be oriented using anatomical landmarks and used to identify the location of the positive biopsy cores. The NanoKnife Single Electrode Probes will be surgically inserted into the prostate through the perineum using MRI/TRUS fusion guidance and the ultrasound grid for guidance.
Study NCT06074029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immune Checkpoint Inhibitors
Description: Immune Checkpoint Inhibitors including Durvalumab, Pembrolizumab and Toripalimab